cardiology careers collections past issues search home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 5


Figure 5 LPS- or Ang II-Induced TUNEL Staining of Cardiac Myocytes Inhibited by BAPTA-AM or Thapsigargin

Terminal deoxy-nucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining of cardiac myocytes (mean % + SE) increased after 24 h with lipopolysaccharide (LPS) (10 ng/ml) or angiotensin II (Ang II) (100 nmol/l) compared with control (vehicle) (p < 0.05). This was blocked by pre-treating myocytes 1 h before LPS or Ang II with: (A) 1,2-Bis(2-amino-5-fluorophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl) ester (BAPTA-AM) (0.1 µmol/l), while BAPTA-AM alone had no effect (n = 5); (B) Thapsigargin (TG) (1 µmol/l), while TG alone had no effect (n = 9).





Right arrow Return to article

 
  cardiology careers collections past issues search home